The Chemours Company (NYSE:CC) Receives Consensus Rating of “Hold” from Analysts

Shares of The Chemours Company (NYSE:CC) have earned a consensus recommendation of “Hold” from the twelve research firms that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and five have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $18.40.

A number of research analysts recently commented on the company. Weiss Ratings restated a “sell (d)” rating on shares of Chemours in a research report on Wednesday, January 21st. JPMorgan Chase & Co. increased their price objective on shares of Chemours from $13.00 to $17.00 and gave the stock a “neutral” rating in a research note on Monday, February 23rd. Morgan Stanley raised their target price on shares of Chemours from $15.00 to $17.00 and gave the company an “equal weight” rating in a report on Monday, February 23rd. Truist Financial boosted their target price on shares of Chemours from $18.00 to $21.00 and gave the company a “buy” rating in a research report on Wednesday, January 21st. Finally, UBS Group upped their price target on shares of Chemours from $18.00 to $23.00 and gave the stock a “buy” rating in a report on Monday, February 23rd.

Chemours Stock Up 4.6%

NYSE CC opened at $18.52 on Tuesday. The company has a current ratio of 1.78, a quick ratio of 0.85 and a debt-to-equity ratio of 16.33. The company has a market cap of $2.78 billion, a price-to-earnings ratio of -7.47 and a beta of 1.60. The company has a 50 day moving average of $17.53 and a 200-day moving average of $14.97. Chemours has a 1-year low of $9.13 and a 1-year high of $21.85.

Chemours (NYSE:CC) last posted its quarterly earnings data on Thursday, February 19th. The specialty chemicals company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.33 billion. Chemours had a positive return on equity of 41.75% and a negative net margin of 6.41%.The company’s revenue was down 2.2% on a year-over-year basis. During the same quarter last year, the company earned $0.09 EPS. On average, equities research analysts expect that Chemours will post 2.03 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Friday, February 27th were issued a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend was Friday, February 27th. Chemours’s dividend payout ratio (DPR) is currently -14.11%.

Institutional Trading of Chemours

Several institutional investors and hedge funds have recently modified their holdings of CC. Entropy Technologies LP raised its stake in Chemours by 478.3% during the second quarter. Entropy Technologies LP now owns 62,075 shares of the specialty chemicals company’s stock worth $711,000 after acquiring an additional 51,341 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new position in shares of Chemours in the third quarter worth about $2,124,000. Vision One Management Partners LP boosted its stake in shares of Chemours by 10.4% in the 2nd quarter. Vision One Management Partners LP now owns 1,720,189 shares of the specialty chemicals company’s stock valued at $19,696,000 after purchasing an additional 161,691 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Chemours by 41.4% during the 2nd quarter. Geode Capital Management LLC now owns 3,484,416 shares of the specialty chemicals company’s stock valued at $39,901,000 after purchasing an additional 1,020,933 shares during the last quarter. Finally, WINTON GROUP Ltd grew its holdings in shares of Chemours by 103.5% during the 3rd quarter. WINTON GROUP Ltd now owns 114,100 shares of the specialty chemicals company’s stock valued at $1,807,000 after purchasing an additional 58,039 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.